Search

everythinglearnresearchcommunity

for

Search:↓

Bullous pemphigoid, intrahepatic cholangiocarcinoma, and alopecia areata may share immune-related causes.

The combination of mitoxantrone, etoposide, and prednisolone is effective for treating relapsed lymphoma with manageable side effects.

High MUC-18/MCAM levels in blood indicate a worse outlook for melanoma patients.

Two cycles of ABVD chemotherapy followed by 20 Gy radiotherapy is the new standard for early-stage Hodgkin lymphoma due to lower toxicity and similar effectiveness.

10% hPL is best for growing mesenchymal stem cells, while 10% FBS is best for hepatocytes.

Bardet-Biedl syndrome may include under-recognized skin problems related to its metabolic disturbances.

Children with alopecia areata have lower BDNF levels, linked to worse symptoms and quality of life.

Botryococcus terribilis Ethanol Extract may reduce inflammation by changing gene expression in cells.

Patients prioritize quality of life, overall survival, and progression-free survival in treatment decisions for advanced breast cancer.

The new bioreactor improves skin grafts by evenly stretching cells and monitoring conditions for better growth.

Early recognition of skin lesions in Birt-Hogg-Dubé syndrome is crucial for detecting renal tumors early.

IMA and IMA/albumin levels don't predict alopecia areata severity.

A rare case showed basal cell carcinoma and leiomyosarcoma coexisting, needing careful diagnosis and treatment.

The new chemotherapy combination of WP 631 and Epothilone B shows enhanced effectiveness against ovarian cancer but requires more research on its safety.

An emollient PLUS balm with ADE-G1 significantly improved skin dryness and quality of life in cancer patients with xerosis.

Changing YBX1 protein activity affects skin stem cell function and aging.

Hematological ratios can effectively predict and manage alopecia areata severity.

Identical twins had different symptoms because one had more cells with an extra chromosome fragment in different tissues.

The study found two new mutations in a Chinese patient with severe biotinidase deficiency.

Blood count parameters are not reliable for predicting recurrent implantation failure.

Two new IRAK4-inhibitors effectively reduced skin inflammation and immune response markers in healthy volunteers.

Patients with Bohring-Opitz syndrome and ASXL1 mutations need regular kidney ultrasounds to check for tumors.

Bicalutamide does not significantly affect liver enzymes and is a safe anti-androgen option for transfeminine individuals.

The calcineurin/NFAT pathway plays a significant role in the development and growth of a type of skin cancer called cutaneous squamous cell carcinoma.

A new 3D breast tumor model helps test drug effects more accurately than traditional methods.

Mutations in the KLHL24 gene cause skin blistering in epidermolysis bullosa simplex.

The combination treatment showed a higher response rate but no significant survival benefits.

Birt–Hogg–Dubé Syndrome requires genetic testing for accurate diagnosis due to its similarities with tuberous sclerosis.

Deleting the MAD2L1 gene is tolerated in certain mouse cancer models.

Inhibiting mTORC2 can reduce DNA repair and increase cancer cell death, suggesting potential for targeted brain cancer treatments.